United Kingdom
  • Booth: 307

InoCardia is a contract research organisation that specialises in the development & execution of novel clinically relevant pre-clinical assays to assess drug effects on the contractility of the heart. These assays will have a greater throughput & predictivity for adverse effects in humans & will be used to test for undesirable effects of new therapeutics on the heart. InoCardia can deliver a more accurate & cost effective way to identify cardiovascular contractility associated drug effects.